ClinicalTrials.gg
Sign In

Drug

Huaier Extract Granule clinical trials

studies test it
24
open now
17
in phase 3
4
first study started
2011

Keep track of what changes. Save the Huaier Extract Granule studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Name

Huaier Granule
23
Z20000109（NMPA Approval Number）
4
Huaier
3
Z20000109#NMPA Approval Number#
3

Combined with it in one product

Tislelizumab plus Huaier granule
1

Studies by the year they started

24 studies that test it; most in 2023 (5)

Studies that test Huaier Extract Granule, by start year
YearStudies
20112
20152
20162
20171
20201
20211
20235
20245
20252
20263

By phase

A phase 1/2 study counts in both.

Phase 2
4
Phase 3
4
Phase 4
14
No phase
3

What it is tested for

Each study’s main condition, where its own words name it.

Colorectal Neoplasms
4
Breast Neoplasms
3
Proteinuria
2
Carcinoma, Non-Small-Cell Lung
2
Pancreatic Neoplasms
2
Neoplasm Metastasis
1
Stomach Neoplasms
1
Ovarian Neoplasms
1
Fallopian Tube Neoplasms
1
Carcinoma, Hepatocellular
1
Carcinoma, Ductal, Breast
1
Glomerulonephritis, Membranous
1

Who runs them

Industry 3 · Other 21

Fudan University (8) · Qidong Gaitianli Medicines Co., Ltd (3) · Xi'an Jiaotong University (2) · Ruijin Hospital (2) · Tongji Hospital (2) · Shandong University (2) · Sixth Affiliated Hospital, Sun Yat-sen University (2) · Xin Ye (1)

Often tested with

Tested in the same studies.

Tislelizumab (1) · Cyclophosphamide (1)

Studies

Open first, then newest update. How each study uses Huaier Extract Granule is read from its arms, and is right about nine times in ten.

Testing it · 24

See all 24 studies that test Huaier Extract Granule →